Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
LYL797 for Breast and Lung Cancer
Recruiting1 awardPhase 1
Detroit, Michigan
This trial will study a new cancer treatment, called LYL797, in patients who have triple negative breast cancer or non-small cell lung cancer that has come back or does not respond to other treatments. The first part of the trial will test different doses of LYL797 to find a safe dose. The second part of the trial will give that dose to additional patients to see if it is effective.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.